- Home
- RVNC vs NUS Comparison
RVNC vs NUS Comparison
Compare RVNC & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- NUS
- Stock Information
- Founded
- RVNC 1999
- NUS 1984
- Country
- RVNC United States
- NUS United States
- Employees
- RVNC N/A
- NUS N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- NUS Other Pharmaceuticals
- Sector
- RVNC Health Care
- NUS Health Care
- Exchange
- RVNC Nasdaq
- NUS Nasdaq
- Market Cap
- RVNC 320.5M
- NUS 348.5M
- IPO Year
- RVNC 2014
- NUS 1996
- Fundamental
- Price
- RVNC $3.67
- NUS $7.32
- Analyst Decision
- RVNC Hold
- NUS Hold
- Analyst Count
- RVNC 9
- NUS 2
- Target Price
- RVNC $7.78
- NUS $6.88
- AVG Volume (30 Days)
- RVNC 2.9M
- NUS 899.6K
- Earning Date
- RVNC 02-26-2025
- NUS 02-13-2025
- Dividend Yield
- RVNC N/A
- NUS 3.31%
- EPS Growth
- RVNC N/A
- NUS N/A
- EPS
- RVNC N/A
- NUS N/A
- Revenue
- RVNC $256,945,000.00
- NUS $1,775,172,000.00
- Revenue This Year
- RVNC $11.28
- NUS N/A
- Revenue Next Year
- RVNC $27.21
- NUS N/A
- P/E Ratio
- RVNC N/A
- NUS N/A
- Revenue Growth
- RVNC 25.82
- NUS N/A
- 52 Week Low
- RVNC $2.30
- NUS $5.95
- 52 Week High
- RVNC $7.56
- NUS $19.30
- Technical
- Relative Strength Index (RSI)
- RVNC 61.28
- NUS 55.85
- Support Level
- RVNC $3.25
- NUS $6.77
- Resistance Level
- RVNC $3.70
- NUS $7.15
- Average True Range (ATR)
- RVNC 0.08
- NUS 0.44
- MACD
- RVNC 0.09
- NUS 0.06
- Stochastic Oscillator
- RVNC 95.52
- NUS 55.45
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
About NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.